Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Ueno, Michihiko ^a   Miyauchi, Takashi ^a,b   Sakai, Satoshi ^a   Kobayashi, Tsutomu ^a   Goto, Katsutoshi ^b   Yamaguchi, Iwao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Atrial natriuretic peptide; B type natriuretic peptide; Cardiac hypertrophy; Myocardial endothelin 1 system; Pressure overload; Pulmonary hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; MONOCROTALINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; GENE EXPRESSION REGULATION; HEART RIGHT VENTRICLE PRESSURE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; QUANTITATIVE DIAGNOSIS; RAT;

EID: 0032762717     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.5.r1321     Document Type: Article

References (55)

1. Adachi, S., H. Ito, Y. Ohta, M. Tanaka, S. Ishiyama, M. Nagata, T. Toyozaki, Y. Hirata, F. Marumo, and M. Hiroe. Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H162-H169, 1995.
2. Appel, R. G. Growth-regulatory properties of atrial natriuretic factor. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F911-F918, 1992.
3. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
4. Bolli, P., F. B. Müller, L. Linder, A. E. G. Raine, T. J. Resink, P. Erne, W. Kiouwski, R. Ritz, and F. R. Bühler. The vasodilator potency of atrial natriuretic peptide in man. Circulation 75: 221-228, 1987.
5. Currie, M. G., D. M. Geller, B. R. Cole, J. G. Boylan, W. YuSheng, S. W. Holmberg, and P. Needleman. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 221: 71-73, 1983.
6. DeBold, A. J., H. B. Borenstein, A. T. Veress, and H. Sonnenberg. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28: 89-94, 1981.
7. 2+ modulation. Circ. Res. 78: 302-311, 1996.
8. Gardner, D. G., C. F. Deschepper, W. F. Ganong, S. Hane, J. Fiddes, J. D. Baxter, and J. Lewicki. Extra-atrial expression of the gene for atrial natriuretic factor. Proc. Natl. Acad. Sci. USA 83: 6697-6701, 1986.
9. Gersony, W. M. Fetal and neonatal circulation. In: Nelson Textbook of Pediatrics (4th ed.), edited by R. E. Behrman. Philadelphia, PA: Saunders, 1992, p. 1144-1146.
10. Goto, K., H. Hama, and Y. Kasuya. Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol. 72: 261-290, 1996.
11. Goto, K., and T. D. Warner. Endothelin versatility. Nature 375: 539-540, 1995.
12. Hama, N., H. Itoh, G. Shirakami, O. Nakagawa, S. Suga, Y. Ogawa, I. Masuda, K. Nakanishi, T. Yoshimasa, Y. Hashimoto, M. Yamaguchi, R. Hori, H. Yasue, and K. Nakao. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92: 1558-1564, 1995.
13. Hirata, Y., E. Suzuki, H. Hayakawa, H. Matsuoka, T. Sugimoto, M. Kojima, K. Kanagawa, and H. Matsuo. Role of endogenous ANP in sodium excretion in rats with experimental pulmonary hypertension. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1684-H1689, 1992.
14. Hutchinson, H. G., P. T. Trindade, D. B. Cunanan, C. F. Wu, and R. E. Pratt. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35: 158-167, 1997.
15. Inoue, A., M. Yanagisawa, Y. Takuwa, Y. Mitsui, M. Kobayashi, and T. Masaki. The human preproendothelin-1 gene. J. Biol. Chem. 264: 14954-14959, 1989.
16. Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H970-H973, 1988.
17. Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflügers Arch. 413: 108-110, 1988.
18. Ito, H., Y. Hirata, M. Hiroe, M. Tsujino, S. Adachi, T. Takamoto, M. Nitta, K. Taniguchi, and F. Marumo. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultures neonatal rat cardiomyocytes. Circ. Res. 69: 209-215, 1991.
19. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 89: 2198-2203, 1994.
20. Kangawa, K., and H. Matsuo. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem. Biophys. Res. Commun. 118: 131-139, 1984.
21. Kangawa, K., Y. Tawaragi, S. Oikawa, A. Mizuno, Y. Sakuragawa, H. Nakazato, A. Fukuda, N. Minamino, and H. Matsuo. Identification of rat atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 312: 152-155, 1984.
22. B receptor-mediated clearance of endothelin-1? Life Sci. 62: 185-193, 1998.
23. Kobayashi, T., T. Miyauchi, S. Sakai, I. Yamaguchi, K. Goto, and Y. Sugishita. Endothelin-converting enzyme and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction. J. Cardiovasc. Pharmacol. 31, Suppl. 1: S417-S420, 1998.
24. Kojima, M., N. Minamino, K. Kagawa, and H. Matsuo. Cloning and sequence of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem. Biophys. Res. Commun. 159: 1420-1426, 1989.
25. Lattion, A. L., J. B. Michael, E. Arnold, P. Corvol, and F. Soberer. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am. J. Physiol. 251 (Heart Circ. Physiol. 20): H890-H896, 1986.
26. Levy, D., K. M. Anderson, D. D. Savage, S. A. Balks, W. B. Kennel, and W. P. Costello. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am. J. Cardiol. 60: 560-565, 1987.
27. Levy, D., R. J. Garrison, D. D. Savage, W. B. Kennel, and W. P. Costello. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322: 1561-1566, 1990.
28. Lin, H. Y., E. H. Kaji, G. K. Winkel, H. E. Ives, and H. F. Lodish. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. USA 88: 3185-3189, 1991.
29. Maeda, S., T. Miyauchi, T. Kobayashi, K. Goto, and M. Matsuda. Exercise causes tissue-specific enhancement of endothelin-1 mRNA expression in internal organs. J. Appl. Physiol. 85: 425-431, 1998.
30. Miyauchi, T., T. Ishikawa, Y. Tomobe, M. Yanagisawa, S. Kimura, Y. Sugishita, I. Ito, K. Goto, and T. Masaki. Characteristics of pressor response to endothelin-1 in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 14: 427-434, 1989.
31. Miyauchi, T., and T. Masaki. Pathophysiology of endothelin in cardiovascular system. Annu. Rev. Physiol. 61: 391-415, 1999.
32. Miyauchi, T., S. Sakai, T. Kobayashi, K. Goto, N. Fujii, H. Miyazaki, I. Yamaguchi, and Y. Sugishita. Expression of endothelin-1 mRNA in the heart of pathological hypertrophy or physiological hypertrophy (Abstract). Jpn. Circ. J. 61: 579, 1997.
33. Miyauchi, T., Y. Tomobe, T. Ishikawa, K. Goto, and Y. Sugishita. Vasoconstriction by endothelin-1 in resistance and conduit portions of isolated human mesenteric arteries. Eur. J. Pharmacol. 303: 193-196, 1996.
34. Miyauchi, T., Y. Tomobe, R. Shiba, T. Ishikawa, M. Yanagisawa, S. Kimura, Y. Sugishita, I. Ito, K. Goto, and T. Masaki. Involvement of endothelin in the regulation of human vascular tonus: potent vasoconstrictor effect and existence in endothelial cells. Circulation 81: 1874-1880, 1990.
35. Miyauchi, T., R. Yorikane, S. Sakai, T. Sakurai, M. Okada, M. Nishikibe, M. Yano, I. Yamaguchi, Y. Sugishita, and K. Goto. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 73: 887-897, 1993.
36. Nihill, M. R. Clinical management of patients with pulmonary hypertension. In: Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult (5th ed.), edited by G. C. Emmanouilides, T. A. Riemenschneider, H. D. Allen, and H. P. Gutgesell. Baltimore, MD: Williams & Wilkins: 1995, p. 1695-1711.
37. Ogawa, Y., K. Nakao, M. Mukoyama, K. Hosoda, G. Shirakami, H. Arai, Y. Saito, S. Suga, M. Jougasaki, and H. Imura. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats: the ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ. Res. 69: 491-500, 1991.
38. Pönicke, K., M. Vogelsang, M. Heinroth, K. Becker, O. Zolk, M. Böhm, H. R. Zerkowski, and O. E. Brodde. Endothelin receptors in the failing and nonfailing human heart. Circulation 97: 744-751, 1998.
39. Sakai, S., T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353-355, 1996.
40. Sakai, S., T. Miyauchi, T. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. Altered expression of isoform of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist. J. Cardiovasc. Pharmacol. 31, Suppl. 1: S302-S305, 1998.
41. Sakai, S., T. Miyauchi, T. Sakurai, Y. Kasuya, M. Ihara, I. Yamaguchi, K. Goto, and Y. Sugishita. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation 93: 1214-1222, 1996.
42. Sakai, S., R. Yorikane, T. Miyauchi, T. Sakurai, Y. Kasuya, T. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. Difference in roles of myocardial endothelin-1 between concentric and eccentric cardiac hypertrophy: an endothelin receptor antagonist inhibits cardiac hypertrophy due to pressure-but not volume-overload in rats. Circulation 94, Suppl. I: I-420, 1996.
43. Sakurai, T., M. Yanagisawa, A. Inoue, U. S. Ryan, S. Kimura, Y. Mitsui, K. Goto, and T. Masaki. cDNA cloning sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 175: 44-47, 1991.
44. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
45. Schunkert, H., L. Jahn, S. Izumo, C. S. Apstein, and B. H. Lorell. Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc. Natl. Acad. Sci. USA 88: 11480-11484, 1991.
46. Shubeita, H. E., P. M. McDonough, A. N. Harris, K. U. Knowlton, C. C. Glembotski, J. H. Brown, and K. R. Chien. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J. Biol. Chem. 265: 20555-20562, 1990.
47. Sudoh, T., K. Kanagawa, N. Minamino, and H. Matsuo. A new natriuretic peptide in porcine brain. Nature 332: 78-81, 1988.
48. Suzuki, T., T. Kumazaki, and Y. Mitsui. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem. Biophys. Res. Commun. 193: 823-830, 1993.
49. Thomas, P. B., E. C. K. Liu, M. L. Webb, R. Mukherjee, L. Hebbar, and F. G. Spinale. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2629-H2637, 1996.
50. 2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension 28: 797-805, 1996.
51. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13: 2485-2502, 1985.
52. Tsuchimochi, H., F. Kurimoto, K. Ieki, H. Koyama, F. Takaku, M. Kawana, S. Kimata, and Y. Yazaki. Atrial natriuretic peptide distribution in fetal and failed adult human hearts. Circulation 78: 920-927, 1988.
53. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
54. Yorikane, R., S. Sakai, T. Miyauchi, T. Sakurai, Y. Sugishita, and K. Goto. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 332: 31-34, 1993.
55. Zhou, H. L., and R. R. Fiscus. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Neuropeptides 14: 161-169, 1989.